Piperlongumine Powder

Selective Reactive Oxygen Species (ROS) Induction & Antioxidant System Inhibition

Targeting GSTP1 and CBR1: Piperlongumine contains α, β-unsaturated amide structures that covalently bind to and inhibit Glutathione S-Transferase P1 (GSTP1) and Carbonyl Reductase 1 (CBR1) via nucleophilic addition.

Depleting Glutathione (GSH): Inhibiting these key antioxidant enzymes depletes intracellular GSH in cancer cells, triggering a dramatic surge in ROS levels, which subsequently induces apoptosis, ferroptosis, or autophagic cell death.

Multi-Target Pathway Modulation

NF-kB Pathway Inhibition: Inhibits IkBα phosphorylation and degradation, blocking the nuclear translocation of NF-kB to exert potent anti-inflammatory and anti-metastatic effects.

STAT3 Signaling Blockade: Suppresses STAT3 phosphorylation and downregulates its downstream anti-apoptotic genes (such as Bcl-xL and Mcl-1).

p53 Reactivation: Reactivates p53-mediated apoptotic programs via ROS-dependent pathways in various p53-mutant or p53-null cancer cells.

Selective Toxicity (Cancer Cells vs. Normal Cells)

Mechanism: Normal cells typically possess lower baseline ROS levels and robust antioxidant buffering capacity, whereas cancer cells exist in a high-ROS state and rely heavily on the GSH antioxidant system.

Effect: At concentrations that effectively kill tumor cells, Piperlongumine exhibits virtually no toxicity toward normal hematopoietic stem cells, normal epithelial cells, and cardiomyocytes.

Blood-Brain Barrier (BBB) Penetration Potential

Owing to its favorable lipophilicity and relatively small molecular weight, studies demonstrate its capacity to cross the blood-brain barrier, showing promising potential in central nervous system research (such as Glioblastoma, GBM).

Anticancer & Antimetastatic Activities

Broad-Spectrum Anticancer Efficacy: Exhibits micromolar (μM) range IC50 values against various cancer types, including breast, prostate, lung, colorectal, pancreatic cancers, and glioblastoma.

Chemosensitization in Combination Therapy: Significantly enhances the sensitivity of cancer cells to conventional chemotherapeutics (e.g., cisplatin, doxorubicin, gemcitabine) and targeted drugs, effectively reversing multidrug resistance (MDR).

Anti-inflammatory, Anti-fibrotic & Neuroprotective Effects

Anti-fibrosis: Suppresses the TGF-β/Smad pathway to attenuate tissue fibrosis in liver, lung, and renal fibrosis models.

Neuroprotection: Inhibits microglial hyperactivation to alleviate neuroinflammatory damage in neurodegenerative diseases.

Cardiovascular & Metabolic Regulation

Inhibits abnormal proliferation of vascular smooth muscle cells (VSMCs), demonstrating potential in preventing atherosclerosis and restenosis.

Piperlongumine has low aqueous solubility, which complicates preparation for cell experiments, oral delivery, and the evaluation of systemic exposure. Researchers have explored delivery systems such as nanoemulsions, but improved exposure with a carrier does not establish clinical efficacy. Animal pharmacokinetic results should be reported alongside the route of administration, vehicle, dose, and analytical method; findings from a formulated product cannot automatically be applied to unformulated powder.

For cell-based studies, the solvent concentration and the compound's actual dissolved state in culture medium should be checked. Otherwise, the nominal concentration added to the medium may differ from the concentration available to cells.

Studies using human liver microsomes have investigated piperlongumine's oxidative metabolism and its resulting metabolites. Such experiments help define questions for subsequent pharmacokinetic and safety studies, but they do not replace human metabolism data, repeated-dose toxicity studies, or drug-interaction assessments.

Because piperlongumine can substantially alter cellular redox status in experimental models, its safety cannot be inferred from its botanical origin or from results in selected normal-cell models. Further research should examine dose and systemic exposure, effects on organs such as the liver, genotoxicity, and risks associated with repeated administration.